Visibility of Neurofibromatosis 1 and Psychiatric Morbidity
- 1 January 2003
- journal article
- other
- Published by American Medical Association (AMA) in Archives of Dermatology
- Vol. 139 (1) , 103-104
- https://doi.org/10.1001/archderm.139.1.103
Abstract
Psychiatric comorbidities have been well documented in patients with neurofibromatosis 1 (NF1),1-3 and none of these psychological or psychiatric conditions are correlated with the severity of somatic symptoms.2,3 We recently published in the ARCHIVES that NF1 has a significant impact on quality of life through alteration of health and appearance.4 While conducting this quality-of-life study, we evaluated the impact of NF1 visibility and severity on psychiatric morbidity.Keywords
This publication has 3 references indexed in Scilit:
- Quality-of-Life Impairment in Neurofibromatosis Type 1Archives of Dermatology, 2001
- Assessing psychological distress in patients with skin diseases: reliability, validity and factor structure of the GHQ‐12Journal of the European Academy of Dermatology and Venereology, 2001
- Psychological aspects of von Recklinghausen neurofibromatosis (NF1)Journal of Medical Genetics, 1995